UNSPSC 51282702: Vancomycin

This classification denotes an antibiotic with the molecular formula C66H75Cl2N9O24, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6Q205EH1VU, chemically known as (s(sub a))-(3s,6r,7r,22r,23s,26s,36r,38ar)-44-((2-o-(3-amino-2,3,6-trideoxy-3-c-methyl-alpha-l-lyxo-hexopyranosyl)-beta-d-glucopyranosyl)oxy)-3-(carbamoylmethyl)-10,19-dichloro-2,3,4,5,6,7,23,24,25,26,36,37,38,38a-tetradecahydro-7,22,28,30,32-pentahydroxy-6-((2r)-4-methyl-2-(methylamino)valeramido)-2,5,24,38,39-pentaoxo-22h-8,11:18,21-dietheno-23,36-(iminomethano)-13,16:31,35- but generally known as vancomycin, which bears US NIH Compound Identifier 14969.

UNSPSC 51282702 Vancomycin is a Commodity code that in recent state and local procurement activity encompasses a broader range of pharmaceutical and medical supply procurement than the code name alone suggests. State and local buyers under this code are purchasing generic pharmaceuticals, over-the-counter (OTC) products, medical and first aid supplies for emergency response, and direct-to-manufacturer prescription fulfillment capabilities. The issuing bodies include state health and human services departments, county health authorities, city fire departments, and multistate cooperative purchasing alliances. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) and Texas Health and Human Services Commission represent state-level buyers seeking to consolidate pharmaceutical sourcing; Seminole County, Florida and the City of Tampa represent county and municipal health and emergency-response buyers. Work typically involves establishing master supply contracts for pharmaceuticals and medical consumables with managed pricing through authorized wholesalers, compliance with FDA and Drug Supply Chain Security Act requirements, cGMP certification, and inventory management across distributed facilities.

Recent activity spans Florida, Texas, and Minnesota, with multistate cooperative purchasing vehicles extending reach across additional jurisdictions including Oregon. Representative opportunities include the Minnesota Multistate Cooperative Purchasing Alliance's RFP (S1070000015802) for generic multi-source pharmaceuticals and OTC products, due March 26, 2026, requiring vendor compliance with DSCSA and cGMP standards and pricing through three authorized wholesalers; the Texas Health and Human Services Commission's RFI (HHS0017013) posted April 3, 2026, exploring direct-to-manufacturer prescription models outside traditional PBM and GPO channels; Seminole County's IFB (IFB60459723LAS) for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, due July 26, 2023; and the City of Tampa's IFB (26P00145) for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, estimated at $700,000.00, with a Small Local Business Enterprise set-aside and 5% bid discount, due March 13, 2026.